The FILTRATE Trial: High-Rate Ultrafiltration for Intravascular Congestion
NCT07705269 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2026-07-15
Summary
The purpose of this study is to evaluate whether a personalized, high-rate fluid removal strategy guided by ultrasound is as safe and effective as the standard fluid removal rate for patients with advanced kidney disease who are hospitalized due to severe fluid overload (congestion).
When patients with End-Stage Renal Disease (ESRD) on chronic hemodialysis are admitted to the hospital with excess fluid, doctors often need to remove this fluid quickly to relieve symptoms like severe shortness of breath. However, traditional guidelines recommend conservative fluid removal rates-called ultrafiltration (UF) rates-between 10 and 13 mL/kg/h to prevent sudden drops in blood pressure (intradialytic hypotension). Despite these guidelines, doctors in real-world hospital settings frequently use higher rates to provide urgent relief, though this practice lacks strong scientific backing.
This study utilizes advanced bedside ultrasound protocols (such as lung ultrasound and VExUS) to objectively measure the amount of fluid congestion inside the patient's blood vessels. The researchers hypothesize that patients with high ultrasound markers of congestion can safely tolerate higher fluid removal rates because their blood vessels are overfilled, meaning fluid can be pulled out faster without causing blood pressure drops.
Participants will be randomly assigned to one of two groups during their first in-hospital hemodyalisis session:
* Standard Group: Receives a standard fluid removal rate of 10 mL/kg/h.
* High-Rate Group: Receives a higher fluid removal rate of over 13 mL/kg/h (with a safety ceiling up to 15 mL/kg/h).
The study will compare the two groups over the first 24 hours to monitor blood pressure stability (safety) and check for improvements in ultrasound congestion scores, shortness of breath, and the need for supplemental oxygen (effectiveness).
Conditions
- End Stage Chronic Renal Failure
- Congestive Heart Failure (CHF)
- Intravascular Congestion
- Fluid Overload
Interventions
- PROCEDURE
-
High-rate ultrafiltration
This intervention consists of fluid removal (ultrafiltration) during the first in-hospital hemodialysis session of a patient with advanced Chronic Kidney Disease, utilizing a high rate greater than 13 mL/kg/h (with a strict safety limit established between \>13 and up to 15 mL/kg/h).The differentiating value of this protocol lies in the fact that it challenges traditional medical dogma by combining an aggressive rate with advanced multiparametric ultrasound tools, something that had not been formally structured in previous clinical trials.
- PROCEDURE
-
Standard fluid removal
Receives a standard fluid removal rate of 10 mL/kg/h.
Sponsors & Collaborators
-
Hospital Universitario Dr. Jose E. Gonzalez
collaborator OTHER -
Universidad Autonoma de Nuevo Leon
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-04
- Primary Completion
- 2027-06-30
- Completion
- 2027-10-31
Countries
- Mexico
Study Locations
More Related Trials
-
Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy
NCT04871893 ·Status: COMPLETED ·Phase: NA
-
Registry for HF20 for Pediatric CRRT Under Emergency Use Authorization
NCT04836026 ·Status: COMPLETED
-
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
NCT07550894 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Analysis of Continuous Kidney Replacement Therapy (CKRT) Treatments With multiFlux Hemofilters Using Regional Citrate Anticoagulation (RCA) or Systemic Heparin Anticoagulation
NCT07679568 ·Status: NOT_YET_RECRUITING
-
Continuous Renal Replacement Therapy Doses in Critically Ill Patients With Acute Kidney Injury
NCT06901011 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions.
NCT05703620 ·Status: RECRUITING ·Phase: NA
-
Clinical Evaluation of the CM-1500 During Hemodialysis
NCT05125848 ·Status: COMPLETED ·Phase: NA
-
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
NCT00753116 ·Status: COMPLETED ·Phase: PHASE1
-
HEmoFiltration With Citric Acid Anticoagulation
NCT03836742 ·Status: COMPLETED
-
Effect of a Furosemide Stress Test-Guided Strategy on Liberation From Continuous Renal Replacement Therapy in Critically Ill Patients With Acute Kidney Injury
NCT06229990 ·Status: RECRUITING ·Phase: PHASE4
-
Prospective, Multi-center, Single-arm, Observational Study. US FDA 522 Pediatric Post Market Surveillance Study.
NCT04608149 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of CRRT Duration on Solute Removal
NCT04458571 ·Status: COMPLETED
-
Hemostatic Profiles in Pediatric CKD
NCT05064267 ·Status: COMPLETED
-
Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy
NCT03078504 ·Status: TERMINATED ·Phase: NA
-
Feasibility of Intradialytic Monitoring During CKRT
NCT07428395 ·Status: ENROLLING_BY_INVITATION
-
Adjusting Fluid Removal Based on Blood Volume in Hemodialysis: A Randomized Study
NCT01988181 ·Status: COMPLETED ·Phase: NA
-
Hemodynamic and Respiratory Tolerance of Intermittent Hemodialysis in Critically Ill Patients
NCT04444765 ·Status: COMPLETED
-
Preventing Acute Renal Failure After Cardiac Surgery in High Risk Patients Using Sodium Bicarbonate Therapy
NCT00522756 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE)
NCT07579390 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Patients Undergoing Continuous Venovenous Hemodiafiltration: Effects of Increased Blood Flow
NCT05796661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fluid Mobilization in Hospitalized Patients With Acute Kidney Injury
NCT04522635 ·Status: COMPLETED ·Phase: PHASE4
-
Fluid Status of Dialysis Subjects
NCT07217041 ·Status: COMPLETED
-
Validation of a Regional Citrate Anticoagulation Protocol in Critically Ill Patients on Continuous Renal Replacement Therapy
NCT07514650 ·Status: RECRUITING ·Phase: NA
-
Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
NCT07262320 ·Status: RECRUITING
-
Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis
NCT01062984 ·Status: COMPLETED ·Phase: NA